Oralgen

DRUG4 trials

Sponsors

Radboud University Medical Center, Artu Biologicals

Conditions

Allergic RhinoconjunctivitisHayfever

Phase 2

Efficacy and Safety of Grass Pollen Sublingual Immunotherapy

CompletedNCT00567346

Artu BiologicalsAllergic Rhinoconjunctivitis

Start: 2006-12-31End: 2008-03-31Updated: 2010-05-05

Long-term Efficacy and Safety Study With Oralgen Grass Pollen

CompletedNCT00824447

Artu BiologicalsAllergic Rhinoconjunctivitis

Start: 2007-08-31End: 2009-01-31Updated: 2010-05-05

Phase 3

A Randomised, Double-blind, Placebo Controlled Study With Oralgen Grass Pollen Rhinoconjunctivitis

Artu BiologicalsAllergic Rhinoconjunctivitis

Start: 2008-12-31End: 2011-12-31Updated: 2010-04-30

Phase 4

Effects of Sublingual Immunotherapy on Grasspollen Allergy

CompletedNCT00150514

Radboud University Medical CenterHayfever

Start: 2002-01-31End: 2006-12-31Target: 38Updated: 2005-09-08